Back
Day Range
$13.20
$13.47
52-Week Range
$6.85
$16.47
Volume
8,683,606
50D / 200D Avg
$14.22
/
$11.17
Prev Close
$13.20
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.4 | 0.4 |
| P/B | 1.0 | 2.9 |
| ROE % | -21.1 | 3.7 |
| Net Margin % | -24.6 | 3.8 |
| Rev Growth 5Y % | -5.4 | 10.0 |
| D/E | 1.0 | 0.2 |
Key Takeaways
Revenue declined -5.44% annually over 5 years
Generating 1.94B in free cash flow
Capital efficient — spends only 2.65% of revenue on capex
Growth
Revenue Growth (5Y)
-5.44%
Revenue (1Y)-2.98%
Earnings (1Y)N/A
FCF Growth (3Y)-8.72%
Quality
Return on Equity
-21.08%
ROIC-6.79%
Net Margin-24.58%
Op. Margin-18.62%
Safety
Debt / Equity
1.00
Current Ratio1.30
Interest Coverage-5.65
Valuation
P/E Ratio
-4.35
P/B Ratio1.04
EV/EBITDAN/A
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.98% | Revenue Growth (3Y) | -3.72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -5.44% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.30B | Net Income (TTM) | -3.51B |
| ROE | -21.08% | ROA | -9.45% |
| Gross Margin | 35.06% | Operating Margin | -18.62% |
| Net Margin | -24.58% | Free Cash Flow (TTM) | 1.94B |
| ROIC | -6.79% | FCF Growth (3Y) | -8.72% |
| Safety | |||
| Debt / Equity | 1.00 | Current Ratio | 1.30 |
| Interest Coverage | -5.65 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | -4.35 | P/B Ratio | 1.04 |
| P/S Ratio | 1.07 | PEG Ratio | -0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.04% |
| Market Cap | 15.31B | Enterprise Value | 28.66B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14.30B | 14.74B | 15.43B | 16.26B | 17.89B |
| Net Income | -3.51B | -634.20M | 54.70M | 2.08B | -1.27B |
| EPS (Diluted) | -3.00 | -0.53 | 0.05 | 1.71 | -1.05 |
| Gross Profit | 5.01B | 5.62B | 6.44B | 6.50B | 5.58B |
| Operating Income | -2.66B | 10.10M | 766.20M | 1.61B | -34.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 37.19B | 41.50B | 47.69B | 50.02B | 54.84B |
| Total Liabilities | 22.48B | 22.87B | 27.22B | 28.95B | 34.35B |
| Shareholders' Equity | 14.71B | 18.64B | 20.47B | 21.07B | 20.49B |
| Total Debt | 14.70B | 14.31B | 18.37B | 19.53B | 23.36B |
| Cash & Equivalents | 1.35B | 734.80M | 991.90M | 1.26B | 701.20M |
| Current Assets | 9.22B | 9.52B | 12.98B | 10.64B | 10.90B |
| Current Liabilities | 7.09B | 5.78B | 7.78B | 6.75B | 9.88B |